Biohaven Pharmaceutical Holding Company Ltd BHVN:NYSE

RT Quote | NYSE | USD
Last | 05/13/21 EDT
66.05quote price arrow down-2.22 (-3.25%)
Volume
469,109
52 week range
42.74 - 100.77

...

Loading . . .
  • Open68.83
  • Day High69.46
  • Day Low65.24
  • Prev Close66.05
  • 52 Week High100.77
  • 52 Week High Date11/18/20
  • 52 Week Low42.74
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap4.298B
  • Shares Out65.07M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-22.94

KEY STATS

  • Open68.83
  • Day High69.46
  • Day Low65.24
  • Prev Close66.05
  • 52 Week High100.77
  • 52 Week High Date11/18/20
  • 52 Week Low42.74
  • 52 Week Low Date05/14/20
  • Market Cap4.298B
  • Shares Out65.07M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change-22.94

RATIOS/PROFITABILITY

  • EPS (TTM)-14.25
  • P/E (TTM)-4.64
  • Fwd P/E (NTM)-5.91
  • EBITDA (MRQ)-714.892M
  • ROE (MRQ)-805.56%
  • Revenue (MRQ)106.30M
  • Gross Margin (MRQ)71.65%
  • Net Margin (MRQ)-809.99%
  • Debt To Equity (MRQ)-265.20%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biohaven Pharmaceutical Holding Company Ltd

There is no recent news for this security.

Profile

MORE
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. The Company's glutamate platform includes three clinical-stage product candidates being developed for the treatment of various neurological indications: trigriluzole for the treatment of obsessive-compulsive disorder (OCD), spinocerebellar...
Declan Doogan M.D.
Chairman
Vlad Coric M.D.
Chief Executive Officer
James Engelhart CPA
Chief Financial Officer
Address
215 Church St
New Haven, CT
06510-1803
United States

Top Peers

SYMBOLLASTCHG%CHG
ADPT
Adaptive Biotechnologies Corp
33.62+0.71+2.16%
PACB
Pacific Biosciences of California Inc
22.30-0.63-2.75%
NTLA
Intellia Therapeutics Inc
60.88-3.12-4.88%
ALLO
Allogene Therapeutics Inc
26.94-1.01-3.61%
BEAM
Beam Therapeutics Inc
66.14-0.74-1.11%